PATENT CLAIM ANALYSIS

Application Number: 16319808
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-08
Patent Classification: ["424", "001890"]

Abstract:
The present invention relates to novel compounds of the formula (I) that can be employed in the selective Tau detection of disorders and abnormalities associated with Tau aggregates such as Alzheimer's disease and other tauopathies using Positron Emission Tomography (PET) Imaging.

Claim (Index 33):
A method of collecting data for predicting responsiveness of a patient suffering from a disorder associated with tau aggregates and being treated with a medicament comprising:\n (a) bringing a sample or a specific body part or body area suspected to contain an tau aggregate into contact with a compound as defined in  claim 11 , which compound specifically binds to the tau aggregate; (b) allowing the compound to bind to the tau aggregate to form a compound/tau aggregate complex; (c) detecting the formation of the compound/tau aggregate complex; (d) optionally correlating the presence or absence of the compound/tau aggregate complex with the presence or absence of tau aggregate in the sample or specific body part or body area; and (e) optionally comparing the amount of the compound/tau aggregate to a normal control value.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 99.0
- Lexical Diversity: 1.14634
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15112672', '14740595', '14486040', '15324141', '15750982']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7174578884247548
- 35 USC 102 Novelty (BERT): 0.5531642076466176
- Combined Prediction Score: 0.7010285203469411
- Mean Citation Score: 325.844132
- Max Citation Score: 440.98587
- Similarity Product: 315.2532095558292

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test